Tests a phone app for patients to check their own brain function at home
Tests a phone app for self-checks of brain function in people with brain tumors.
Plain-language title generated from the registry record
Registry title: Self-administered Remote Neurological Examination Using Mobile Application in Patients With Brain Tumors
Key facts
- Where
- Mumbai, IndiaSee the site
Where in India
- Tata Memorial CentreMumbai, IndiaTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Tata Memorial Centre
- Trial code
- NCT07236840
- Record updated
- 24 February 2026
- Original description
The goal of this observational study is to evaluate the feasibility and accuracy of a self-administered remote neurological examination using the "Iskhaa" mobile application in patients with brain tumors aged above 5 years who are able to follow app-based instructions.Read full original descriptionShow less
Self-administered Remote Neurological Examination Using Mobile Application in Patients With Brain Tumors
The goal of this observational study is to evaluate the feasibility and accuracy of a self-administered remote neurological examination using the "Iskhaa" mobile application in patients with brain tumors aged above 5 years who are able to follow app-based instructions.
The main questions it aims to answer are:
1. Development of a mobile application equipped with symptom assessment and recording videos as patients perform specific neurological tasks. 2. Development and validation of the AI model to detect functional changes and predict subsequent neurological deterioration.
Participants will:
1. Use the Iskhaa mobile application to perform guided self-neurological examinations following pre-recorded video instructions. 2. Complete EORTC QLQ-C30 and BN20 questionnaires for quality of life assessment. 3. Record and upload videos (e.g., speech, walking, limb movements) using their mobile camera for analysis. 4. In Phase 1 (onsite), 100 participants will use the app under supervision to ensure usability and accuracy. 5. In Phase 2 (offsite), 500 participants will use the app independently at home for monthly self-assessments, with reminders and follow-up support. 6. Continue routine clinic visits every 3-6 months and imaging every 6-12 months as per standard clinical care.
The study will compare app-recorded data with physician assessments to determine agreement and validity of remote neurological monitoring using artificial intelligence analysis.
Inclusion: Diagnosis of brain tumors (histopathology/ radiology); Age > 5 years; Patient or caregiver have access to an android smart phone and is able to install the mobile application; Expected survival more than 6 months during study accrual; Signing patient consent or parent consent/ child assent form (as appropriate).
Exclusion: Patient with severe cognitive or psychiatric issues causing difficulty in using the app or follow instructions; Terminal illness with expected life expectancy (<6 months); Patient or caregiver is not reliable to follow instructions or use the mobile application; Karnofsky Performance Status (KPS) or Lansky Performance Status LPS) <50.